> top > docs > PMC:7205724 > spans > 22500-22807 > annotations

PMC:7205724 / 22500-22807 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
788 103-106 Gene denotes IL6 Gene:3569
789 286-289 Gene denotes CRP Gene:1401
791 79-87 Species denotes Patients Tax:9606
793 44-55 Chemical denotes Tocilizumab MESH:C502936
794 143-154 Chemical denotes tocilizumab MESH:C502936
795 220-226 Chemical denotes oxygen MESH:D010100

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T164 260-270 Body_part denotes lymphocyte http://purl.org/sig/ont/fma/fma62863

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T268 96-97 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T269 130-132 http://purl.obolibrary.org/obo/CLO_0008426 denotes pg

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T171 143-154 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T172 220-226 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T22 220-255 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes oxygen saturation and normalization http://purl.bioontology.org/ontology/MEDDRA/10033322

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T102 196-204 http://purl.obolibrary.org/obo/OGMS_0000020 denotes symptoms

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T110 220-226 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T184 79-297 Sentence denotes Patients who had a mean IL6 level of more than 100 pg/ml before tocilizumab treatment showed improvement in clinical symptoms and peripheral oxygen saturation and normalization for lymphocyte proportion and CRP levels.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
793 44-55 Chemical denotes Tocilizumab MESH:C502936
791 79-87 Species denotes Patients Tax:9606
788 103-106 Gene denotes IL6 Gene:3569
794 143-154 Chemical denotes tocilizumab MESH:C502936
795 220-226 Chemical denotes oxygen MESH:D010100
789 286-289 Gene denotes CRP Gene:1401

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T2161 103-106 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0
T2205 286-289 Protein denotes CRP https://www.uniprot.org/uniprot/Q5U0J2|https://www.uniprot.org/uniprot/Q07203|https://www.uniprot.org/uniprot/Q01687|https://www.uniprot.org/uniprot/P97315|https://www.uniprot.org/uniprot/P67967|https://www.uniprot.org/uniprot/P67966|https://www.uniprot.org/uniprot/P47875|https://www.uniprot.org/uniprot/P32965|https://www.uniprot.org/uniprot/P21291|https://www.uniprot.org/uniprot/P08462|https://www.uniprot.org/uniprot/A8K268

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T44653 3-5 CC denotes or
T55941 6-14 JJ denotes critical
T85453 15-23 VBD denotes received
T98598 24-27 CD denotes one
T96881 28-30 CC denotes or
T24534 31-34 CD denotes two
T70238 35-40 NNS denotes doses
T20616 41-43 IN denotes of
T68912 44-55 NNP denotes Tocilizumab
T98192 56-60 CC denotes plus
T20706 61-69 JJ denotes standard
T58005 70-77 NN denotes therapy
T96625 79-87 NNS denotes Patients
T75572 88-91 WP denotes who
T31917 92-95 VBD denotes had
T15301 96-97 DT denotes a
T24848 98-102 JJ denotes mean
T84688 103-106 NN denotes IL6
T96963 107-112 NN denotes level
T6930 113-115 IN denotes of
T90933 116-120 JJR denotes more
T81944 121-125 IN denotes than
T75581 126-135 NN denotes 100 pg/ml
T64021 136-142 IN denotes before
T9387 143-154 NN denotes tocilizumab
T84664 155-164 NN denotes treatment
T18203 165-171 VBD denotes showed
T60803 172-183 NN denotes improvement
T44490 184-186 IN denotes in
T81402 187-195 JJ denotes clinical
T14228 196-204 NNS denotes symptoms
T94537 205-208 CC denotes and
T83697 209-219 JJ denotes peripheral
T13978 220-226 NN denotes oxygen
T35808 227-237 NN denotes saturation
T34900 238-241 CC denotes and
T75964 242-255 NN denotes normalization
T84268 256-259 IN denotes for
T65028 260-270 NN denotes lymphocyte
T34390 271-281 NN denotes proportion
T96610 282-285 CC denotes and
T30755 286-289 NN denotes CRP
T63070 290-296 NNS denotes levels
T31791 298-302 RB denotes Also
T31152 302-303 -COMMA- denotes ,
R81194 T55941 T44653 arg2Of critical,or
R42123 T70238 T85453 arg2Of doses,received
R67132 T70238 T98598 arg1Of doses,one
R74424 T98598 T96881 arg1Of one,or
R53734 T24534 T96881 arg2Of two,or
R5731 T70238 T24534 arg1Of doses,two
R65601 T70238 T20616 arg1Of doses,of
R56743 T98192 T20616 arg2Of plus,of
R89899 T68912 T98192 arg1Of Tocilizumab,plus
R61440 T58005 T98192 arg2Of therapy,plus
R97353 T58005 T20706 arg1Of therapy,standard
R37793 T96625 T75572 arg1Of Patients,who
R91228 T96625 T31917 arg1Of Patients,had
R53068 T96963 T31917 arg2Of level,had
R75826 T96963 T15301 arg1Of level,a
R53187 T96963 T24848 arg1Of level,mean
R88261 T96963 T84688 arg1Of level,IL6
R96088 T96963 T6930 arg1Of level,of
R5373 T90933 T6930 arg2Of more,of
R57258 T90933 T81944 arg1Of more,than
R94369 T75581 T81944 arg2Of 100 pg/ml,than
R45661 T90933 T64021 arg1Of more,before
R79916 T84664 T64021 arg2Of treatment,before
R78642 T84664 T9387 arg1Of treatment,tocilizumab
R8185 T96625 T18203 arg1Of Patients,showed
R51850 T94537 T18203 arg2Of and,showed
R12091 T60803 T44490 arg1Of improvement,in
R66809 T14228 T44490 arg2Of symptoms,in
R61551 T14228 T81402 arg1Of symptoms,clinical
R5554 T60803 T94537 arg1Of improvement,and
R21619 T34900 T94537 arg2Of and,and
R92393 T35808 T83697 arg1Of saturation,peripheral
R24887 T35808 T13978 arg1Of saturation,oxygen
R90774 T35808 T34900 arg1Of saturation,and
R67692 T75964 T34900 arg2Of normalization,and
R62752 T34900 T84268 arg1Of and,for
R8244 T63070 T84268 arg2Of levels,for
R10896 T63070 T65028 arg1Of levels,lymphocyte
R57903 T63070 T34390 arg1Of levels,proportion
R97168 T34390 T96610 arg1Of proportion,and
R13130 T30755 T96610 arg2Of CRP,and
R88299 T63070 T30755 arg1Of levels,CRP

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T164 260-270 Body_part denotes lymphocyte http://purl.org/sig/ont/fma/fma62863

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T184 79-297 Sentence denotes Patients who had a mean IL6 level of more than 100 pg/ml before tocilizumab treatment showed improvement in clinical symptoms and peripheral oxygen saturation and normalization for lymphocyte proportion and CRP levels.